Accolade Inc (ACCD)
13.61
+0.36
(+2.72%)
USD |
NASDAQ |
Mar 24, 16:00
13.63
+0.02
(+0.15%)
After-Hours: 20:00
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 992.08M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -19.21% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 2.653 |
| Price to Book Value | 2.042 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.5801 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | -- |
News
Headline
Wire
Time (ET)
Yahoo
02/16 10:47
Events
| DATE | TIME | TYPE | PERIOD | REPORTED EPS |
ESTIMATED EPS |
SURPRISE | |
| 04/28/2023* | 16:30 EST | Earnings Call | Q4 2023 | -- | -- | -- | |
| 04/28/2023* | -- | Results | Q4 2023 | -- | -0.24 | -- | |
| 01/09/2023 | 16:30 EST | Earnings Call | Q3 2023 | -- | -- | -- | |
| 01/09/2023 | -- | Results | Q3 2023 | -0.30 | -0.43 | 30.42% | |
| 10/06/2022 | -- | Results | Q2 2023 | -0.37 | -0.50 | 26.73% | |
| 10/06/2022 | 16:30 EST | Earnings Call | Q2 2023 | -- | -- | -- | |
| 06/30/2022 | -- | Results | Q1 2023 | -0.39 | -0.43 | 9.60% | |
| 06/30/2022 | 16:30 EST | Earnings Call | Q1 2023 | -- | -- | -- |
*Estimated Date/Time
Earnings
Profile
Edit
| Accolade Inc offers technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits. It generates revenue by providing personalized health guidance solutions to members. |
| URL | https://www.accolade.com |
| Investor Relations URL | https://ir.accolade.com/ |
| HQ State/Province | Washington |
| Sector | Healthcare |
| Industry | Health Information Services |
| Equity Style | Small Cap/Blend |
| Next Earnings Release | Apr. 28, 2023 (est.) |
| Last Earnings Release | Jan. 09, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Dividends
| Dividend Per Share (TTM) | -- |
|
2017
2018
2019
2020
2021
6.00%
4.00%
2.00%
|
|
| Yield to Market | 0.00 |
| Yield to Sector | 0.00 |
| Yield to Industry | 0.00 |
| Last Dividend Amt. | -- |
| Dividend Frequency | -- |
| Last Ex-Dividend Date | -- |
| Yield (TTM) | 0% |
| Forward Yield | -- |
| Payout Ratio | 0.00% |
| Cash Payout Ratio | 0.00% |
| Consistent Payer (5Y) | No |
| Consistent Growth (5Y) | No |
Risk
Total Returns Comparison
Annual Total Returns Versus Peers
As of March 23, 2023.
Fundamentals
| Revenue (TTM) | 357.87M |
| Total Expenses (TTM) | 527.44M |
| Net Income (TTM) | -463.77M |
| Total Assets (Quarterly) | 913.79M |
| Total Liabilities (Quarterly) | 427.84M |
| Shareholders Equity (Quarterly) | 485.95M |
| Cash from Operations (TTM) | -40.43M |
| Cash from Investing (TTM) | -5.347M |
| Cash from Financing (TTM) | 5.432M |
Ratings
Profile
Edit
| Accolade Inc offers technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits. It generates revenue by providing personalized health guidance solutions to members. |
| URL | https://www.accolade.com |
| Investor Relations URL | https://ir.accolade.com/ |
| HQ State/Province | Washington |
| Sector | Healthcare |
| Industry | Health Information Services |
| Equity Style | Small Cap/Blend |
| Next Earnings Release | Apr. 28, 2023 (est.) |
| Last Earnings Release | Jan. 09, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ownership
| Insider Ownership Percentage | Upgrade |
Jul '20
Nov '20
Mar '21
80.00%
40.00%
10.00%
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Other Resources
| Whale Wisdom | 13F Filings |
| Seeking Alpha | Call Transcripts |
| Nasdaq | Insider Trading |
| Nasdaq | Institutional Ownership |
| Nasdaq | Option Chain |
| SEC | SEC Filings |
| ACCD Tweets |